Researchers in Taiwan mapped a 25-microRNA regulatory network driving radioresistance in head and neck cancer and used ...
A new review in Medical Oncology argues that simultaneously inducing the iron-driven cell death ferroptosis and the ...
Neuroblastoma is an aggressive form of solid cancer in children. The malignancy originates in the nervous system and quickly ...
It takes a great deal of strength and courage to face painful thoughts, feelings, and past experiences. But courage is a ...
Expanding pipelines to go beyond merely single-agent targeted therapies brings forth an active approach to treating ...
OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the ...
Heart and kidney complications remain a major concern for people living with type 1 diabetes (T1D). While there are some therapies available to reduce the risk of these complications, the T1D ...
Standardized patient-derived glioblastoma organoids mirrored patients' radiotherapy responses and showed BET inhibitors may overcome radiation resistance.
San Diego-based biotech KymaThera has banked $80m in a Series B funding round to bring a breast cancer drug to clinic that it claims may overcome the challenges linked to current PI3Kα-targeting ...
Lead ADC candidate BYON14156 harnesses company’s first-in-class antifolate payload platform to overcome major payload resistance challenge seen ...
A new preclinical study reveals that KRAS-mutant gastric adenocarcinoma fosters a TGF-beta-dependent immunosuppressive tumour ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that 21 abstracts from its oncology portfolio will be presented at the European Society for Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results